International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
OpenAlex
Works that cite this article, indexed by OpenAlex.
Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
BMC Endocrine Disorders 21(1) (2021)
Fereidoun Azizi; Hengameh Abdi; Atieh Amouzegar
Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves’ disease: a systematic scoping review
Journal of Endocrinological Investigation 45(6) (2022)
Fereidoun Azizi; Hengameh Abdi; Ladan Mehran; Atieh Amouzegar
Long-term thionamide antithyroid treatment of Graves' disease
Best Practice & Research Clinical Endocrinology & Metabolism 37(2) (2022)
Fereidoun Azizi; Hengameh Abdi; Atieh Amouzegar; Ali Siamak Habibi Moeini
Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves’ Disease
The Journal of Clinical Endocrinology & Metabolism 109(10) (2024)
Fereidoun Azizi; Ladan Mehran; Hengameh Abdi; Atieh Amouzegar
Risk of recurrence at the time of withdrawal of short- or long-term methimazole therapy in patients with Graves’ hyperthyroidism: a randomized trial and a risk-scoring model
Endocrine 84(2) (2024)
Fereidoun Azizi; Atieh Amouzegar; Davood Khalili; Hengameh Abdi; Maryam Tohidi; Mehdi Hedayati; Leila Cheraghi; Yadollah Mehrabi; Miralireza Takyar
A Predictive Model for Graves’ Disease Recurrence After Antithyroid Drug Therapy: A Retrospective Multicenter Cohort Study
Endocrine Practice 31(4) (2024)
Omar M. El Kawkgi; David Toro-Tobón; Freddy J.K. Toloza; Sebastián Vallejo; Cristian Soto Jacome; Ivan N. Ayala; Bryan Alexis Vallejo; Camila Wenczenovicz; Olivia Tzeng; Horace Jack Spencer; Jeff D. Thostenson; Dingfeng Li; Jacob D. Kohlenberg; Eddy P. Lincango-Naranjo; Sneha Mohan; Jessica Castellanos-Diaz; Spyridoula Maraka; Naykky Singh Ospina; Juan Pablo Brito
The evolving therapeutic landscape of Graves’ disease in adults: present and future
European Thyroid Journal 14(4) (2025)
Marius Nicolae Stan; Chrysoula Dosiou
Sustained Euthyroidism during Thionamide Antithyroid Drug Treatment: Comparison of Short- and Long-term Methimazole Therapy
Intern J Endocrinol Metab 22(1) (2024)
Navid Saadat; Safdar Masoumi; Mohammad Karim Shahrzad; Fereidoun Azizi
Iodide-sensitive Graves’ hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment
Endocrine Journal 69(8) (2022)
Ken Okamura; Kaori Sato; Megumi Fujikawa; Sachiko Bandai; Hiroshi Ikenoue; Takanari Kitazono
The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease
Endocrinology and Metabolism 38(3) (2023)
Jin Sok Yu; Han-Sang Baek; Chaiho Jeong; Kwanhoon Jo; Jeongmin Lee; Jeonghoon Ha; Min Hee Kim; Jung‐Min Lee; Dong‐Jun Lim
Long-Term Follow-up of Graves Orbitopathy After Treatment With Short- or Long-Term Methimazole or Radioactive Iodine
Endocrine Practice 29(4) (2023)
Fereidoun Azizi; Hengameh Abdi; Ladan Mehran; Petros Perros; Safdar Masoumi; Atieh Amouzegar
Detection rate and clinical characteristics of coexisting autoimmune diseases in children with Graves’ disease: a single-center study from China
Endocrine 88(1) (2025)
Yang Li; Mu-Qiao Yan; Yan-Ning Song; Qin Zhang; Chunxiu Gong
Long-Term Antithyroid Drug Therapy in the Management of Graves’ Hyperthyroidism: An Updated Narrative Review
Endocrine Practice 32(10) (2026)
Fereidoun Azizi
A New Perspective in the Management of Graves’ Hyperthyroidism
Intern J Endocrinol Metab 18(Suppl) (2020)
Fereidoun Azizi
A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves’ Hyperthyroidism?
Intern J Endocrinol Metab 18(4) (2020)
Hengameh Abdi; Seyed Rasoul Zakavi; Fereidoun Azizi
Biomarker Test Characteristics and Their Relationship to Healthcare Practices in Iraqi Patients Receiving Hyperthyroidism Treatment
Jundishapur Journal of Chronic Disease Care 14(3) (2025)
Mohammed H. Dawood; Muntadher H. Dawood; Mohammed Al-Nussairawi; Mahmoud Gharbavi